메뉴 건너뛰기




Volumn 34, Issue 4, 2010, Pages

Clonal evolution at leukemic relapse of multiple myeloma (secondary plasma cell leukemia) responding to re-treatment with bortezomib-based therapy. A case record

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; BORTEZOMIB; CD19 ANTIGEN; CD38 ANTIGEN; CD56 ANTIGEN; DEXAMETHASONE; DOXORUBICIN; ERYTHROPOIETIN; MELPHALAN; PREDNISONE; SYNDECAN 1; THALIDOMIDE;

EID: 76749157360     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.10.008     Document Type: Letter
Times cited : (7)

References (6)
  • 1
    • 63349090515 scopus 로고    scopus 로고
    • A retrospective analysis of thirty-one cases of plasma cell leukemia from a single center in China
    • Peijing Q., Yan X., Yafei W., Dehui Z., Zengjun L., Junyuan Q., et al. A retrospective analysis of thirty-one cases of plasma cell leukemia from a single center in China. Acta Haematol 121 April (1) (2009) 47-51
    • (2009) Acta Haematol , vol.121 , Issue.April 1 , pp. 47-51
    • Peijing, Q.1    Yan, X.2    Yafei, W.3    Dehui, Z.4    Zengjun, L.5    Junyuan, Q.6
  • 2
  • 3
    • 35449008496 scopus 로고    scopus 로고
    • Significantly better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia
    • [Epub 2007 Oct 11]
    • Cha C.H., Park C.J., Huh J.R., Chi H.S., Suh C.W., and Kang Y.K. Significantly better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia. Acta Haematol 118 3 (2007) 178-182 [Epub 2007 Oct 11]
    • (2007) Acta Haematol , vol.118 , Issue.3 , pp. 178-182
    • Cha, C.H.1    Park, C.J.2    Huh, J.R.3    Chi, H.S.4    Suh, C.W.5    Kang, Y.K.6
  • 4
    • 84988241358 scopus 로고    scopus 로고
    • International uniform response criteria for multiple myeloma
    • Durie B.G., Harosseau J.l., San Miguel J.S., et al. International uniform response criteria for multiple myeloma. Leukemia 20 (2006) 1467-1473
    • (2006) Leukemia , vol.20 , pp. 1467-1473
    • Durie, B.G.1    Harosseau, J.l.2    San Miguel, J.S.3
  • 5
    • 14844293878 scopus 로고    scopus 로고
    • Bortezomib is an efficient agent in plasma cell leukemias
    • Esparis-Ogando A., Alegre A., Aguado B., et al. Bortezomib is an efficient agent in plasma cell leukemias. Int J Cancer 114 (2005) 665-667
    • (2005) Int J Cancer , vol.114 , pp. 665-667
    • Esparis-Ogando, A.1    Alegre, A.2    Aguado, B.3
  • 6
    • 34249088967 scopus 로고    scopus 로고
    • Efficacy and safety of bortezomib in patients with plasma cell leukemia
    • Musto P., Rossini F., Gay F., Pitini V., Guglielmelli T., D'Arena G., et al. Efficacy and safety of bortezomib in patients with plasma cell leukemia. Cancer 109 (2007) 2285-2290
    • (2007) Cancer , vol.109 , pp. 2285-2290
    • Musto, P.1    Rossini, F.2    Gay, F.3    Pitini, V.4    Guglielmelli, T.5    D'Arena, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.